Models Models MuPrime™ Bladder Cancer

Bladder Cancer Tumor Homograft Models

MuPrime tumor homograft models provide an ideal platform to investigate your novel surrogate or cross-reactive agent with competent murine immunity, and the presence of relevant mutations for bladder cancer such as PTEN loss and KRAS activation. Our bladder cancer tumor homografts combine the predictive power of GEMM with the operational symplicity required for pharmacology studies.

MODEL NUMBERORIGINAL GEMM MUTATION # per page
mBL6078KRAS (G12D); PtenFlox/FloxCLICK TO VIEW

Create Account to View All Model Data

Already Registered? Login